Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

The importance of cavitary spaces in retinoblastoma

RAFAEL NOJIRI MOREIRA; Jade Lasiste; Isabela Vianello Valle; Maria Eugenia Orellana; Elvira Barbosa Abreu; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2320.

ARVO Annual Meeting Abstract June 2017

HER2 expression in retinoblastoma: a potential therapeutic target?

David Cordeiro Sousa; Pablo Zoroquiain; Evangelina Esposito; Maria Eugenia Orellana; Bruna Duarte Moron de Andrade; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1776.

ARVO Annual Meeting Abstract April 2014

The effect of 17-AAG on focal adhesion kinase expression in uveal melanoma cell lines

Dana Faingold; Silvin Bakalian; Vasco Bravo-Filho; Henry A Wood; Maria Eugenia Orellana; Emilia Antecka; Miguel N Burnier

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5063.

ARVO Annual Meeting Abstract April 2011

Expression of Hypoxia Inducible Factor-1-α (HIF-1-α) in Retinoblastoma

Patricia R. Odashiro; Alexandre N. Odashiro; Sebastian Di Cesare; Emilia Antecka; Maria Eugenia Orellana; Miguel N. Burnier Jr

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2474.

ARVO Annual Meeting Abstract April 2011

Pax6 Expression In Retinoblastoma

Sheila Smiley; Tiffany Poraccio; Alexandre N. Odashiro; Patricia R. Pereira Odashiro; Maria Eugenia Orellana; Miguel N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2477.

ARVO Annual Meeting Abstract April 2011

Investigation Of N-CoR Localization And Prognostic Value In Human Retinoblastoma

Bassel Nazha; Emilia Antecka; Bruno F. Fernandes; Shawn C. Maloney; Maria Eugenia Orellana; Miguel N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2107.

ARVO Annual Meeting Abstract April 2010

Immunohistochemistry of Conjunctival Melanocytic Lesions: Cox-2, C-Kit and PDGFR as Possible Therapeutic Targets

G. A. Novais; M. E. Orellana; B. F. Fernandes; S. Di Cesare; E. Antecka; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):848.

ARVO Annual Meeting Abstract April 2010

Sirt1 Involvement in Mouse and Human Retinal Development and Function

S. C. Maloney; E. Antecka; T. Granner; B. F. Fernandes; B. A. Tucker; M. E. Orellana; M. Eghtedari; M. Young; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2644.

ARVO Annual Meeting Abstract April 2010

Immunohistochemical Profile Comparing Nodular and Morphea Type Basal Cell Carcinomas and Papillomas of the Eyelid

M. E. Orellana; G. A. Novais; D. M. Abdulmannan; S. C. Maloney; S. Di Cesare; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3517.

ARVO Annual Meeting Abstract April 2009

Lysyl Oxidase: A Potential Metastasis Promoting Gene in Uveal Melanoma

D. A. Abourbih; S. Di Cesare; P. Logan; M. E. Orellana; H. Solari; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):5774.

ARVO Annual Meeting Abstract April 2009

Toll-like Receptor 3 is Expressed in RPE cells of Choroidal Neovascular Membranes

S. C. Maloney; E. Antecka; M. E. Orellana; P. Logan; D. Abourbih; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2950.

ARVO Annual Meeting Abstract April 2009

Expression of SIRT1 in Primary Human Uveal Melanoma

H. R. Oltean; S. C. Maloney; E. Antecka; M. E. Orellana; B. F. Fernandes; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3381.

ARVO Annual Meeting Abstract April 2009

Immunohistochemical Analysis of Retinoblastoma Cell Phenotype Using Neural and Glial Cell Markers

M. E. Orellana; E. Antecka; S. C. Maloney; J. Bush; D. Abdulmannan; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1691.

ARVO Annual Meeting Abstract May 2008

Expression of Sirt1 in Retinoblastoma: A Potential Therapeutic Target

R. N. Vianna; B. F. Fernandes; C. Martins; E. Antecka; M. E. Orellana; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):24.

ARVO Annual Meeting Abstract May 2007

Clinical Pathological Study of a Cohort of Retinoblastoma Patients From a Developing Country

M. E. Orellana; B. F. Fernandes; C. Arean; I. Pifano; C. Abreu; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1603.

ARVO Annual Meeting Abstract May 2007

Immune Expression and Inhibition of Hsp90 in Retinoblastoma

C. Miyamoto; M. E. Orellana; D. Faingold; L. R. M. Santos; C. Martins; E. Antecka; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1604.

ARVO Annual Meeting Abstract May 2007

Expression of C-kit in Retinoblastoma: A Potential Therapeutic Target

R. J. Barry; L. R. M. Santos; J.-C. Marshall; M. E. Orellana; C. Martins; M. N. Burnier, Jr.

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1605.

Advertisement